Distribution of clinicopathological characteristics, cytoplasmic (c), and membranous (m) ALCAM expression
| Characteristic | Number of patients | Per cent of patients |
|---|---|---|
| ALCAM, activated leucocyte cell adhesion molecule. | ||
| Astler-Coller stage | ||
| A | 6 | 5.4 |
| B1 | 21 | 19.0 |
| B2 | 36 | 32.4 |
| C1 | 5 | 4.5 |
| C2 | 34 | 30.6 |
| D | 9 | 8.1 |
| Tumour stage | ||
| T1 | 6 | 5.4 |
| T2 | 26 | 23.4 |
| T3 | 67 | 60.4 |
| T4 | 12 | 10.8 |
| Lymph node status | ||
| Nx | 3 | 2.7 |
| N0 | 63 | 56.8 |
| N1 | 22 | 19.8 |
| N2 | 23 | 20.7 |
| Metastasis | ||
| Mx | 102 | 91.9 |
| M1 | 9 | 8.1 |
| Grading | ||
| G1 | 5 | 4.5 |
| G2 | 87 | 78.4 |
| G3 | 19 | 17.1 |
| Age at diagnosis | ||
| <65 | 52 | 46.8 |
| >65 | 59 | 53.2 |
| cALCAM | ||
| Negative | 46 | 41.4 |
| Positive | 65 | 58.6 |
| mALCAM | ||
| Negative | 77 | 69.4 |
| Positive | 34 | 30.6 |